Danville, CA, United States of America

Christopher L Petersen

This inventor holds 4 USPTO granted patents. Top assignee: Carl Zeiss Gmbh. Active years: 1996-2000.


% Patents Active = 100.0

Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 481(Granted Patents)


Company Filing History:


Years Active: 1996-2000

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Christopher L Petersen

Introduction

Christopher L Petersen is a notable inventor based in Danville, California. He has made significant contributions to the field of optical coherence tomography and visual field testing. With a total of four patents to his name, Petersen's work showcases his dedication to advancing medical technology.

Latest Patents

One of his latest patents is for an optical coherence tomography apparatus that provides efficient scanning. This invention includes a source of short coherence radiation, a coupler for directing the radiation, and a measurement range variation apparatus. Another significant patent is a refractively corrected, wavelength selective, transparent visual field test occluder. This device is designed for use in visual field testing, allowing for precise measurement by filtering specific color spectral ranges.

Career Highlights

Christopher L Petersen is currently employed at Carl Zeiss GmbH, a company renowned for its optical and optoelectronic technology. His work at this organization has allowed him to develop innovative solutions that enhance diagnostic capabilities in medical settings.

Collaborations

Petersen has collaborated with notable colleagues such as Thomas Hellmuth and Jay Wei. These partnerships have contributed to the successful development of his patented technologies.

Conclusion

Christopher L Petersen's contributions to optical coherence tomography and visual field testing exemplify his innovative spirit and commitment to improving medical technology. His patents reflect a deep understanding of the complexities involved in these fields, making him a valuable asset to the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…